Guillaume Pfefer, CEO of Senda Biosciences & Flagship Pioneering CEO-Partner, describes Senda’s work to unlock comprehensive programming of medicine and what is in store for the company in the year ahead. More from Flagship @ JPM2023 here.
More from:
Human Health
What If We Could See Disease Coming and Stop It?
Amanda Kay on a New Approach to Biopharma Partnerships
Pioneering Partnerships: Advancing a Portfolio of Novel Medicines and Vaccines with GSK
Pioneering Partnerships: Accelerating our Collaboration with Pfizer
Unlocking Therapeutic Breakthroughs with the Power of Platform Technologies
